Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease progression.
Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment ...
IEEE Spectrum on MSN22h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Study Finds on MSN2d
Researchers uncover serious flaw in promising Alzheimer’s blood testsDamaged muscles in ALS patients release proteins previously linked only to brain disease In a nutshell Researchers discovered ...
Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully help contribute to ending ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback